Brighthouse 10-Q: Q3 EPS $5.21, Book Value Falls to $5.0B on AOCI; Fitch Cuts to Negative Watch
BHF is trading near its 52-week low of $41.01 (9.7% above the low).
Summary
Brighthouse's Q3 10-Q confirms $5.21 diluted EPS and $527 million adjusted earnings, but shows book value sliding to $5.0 billion on a $5,968 million AOCI hole and discloses a Fitch Rating Watch Negative as the Aquarian merger timeline slips.
Key Events · Earnings and Guidance · BHF
-
Q3 EPS $5.21, Boosted by Actuarial Review
Net income available to common shareholders was $302 million, or $5.21 per diluted share, versus $453 million, or $7.89, a year earlier; the quarter included a $278 million net favorable impact from the GAAP annual actuarial review.
-
Adjusted Earnings $9.12, Only $3.68 Ex-Notables
Adjusted earnings were $527 million, or $9.12 per diluted share, but $314 million ($5.42 per share) was favorable notable items, leaving $213 million, or $3.68 per diluted share.
-
Book Value Falls to $5.0B on AOCI
Total stockholders' equity dropped to $5,011 million at September 30, 2026 from $6,768 million at December 31, 2025, as accumulated other comprehensive income fell to -$5,968 million from -$3,729 million; unrealized fixed-maturity losses widened to $8,931 million from $4,968 million.
-
Fitch Places Ratings on Negative Watch
On November 5, 2026, Fitch placed the long-term issuer credit ratings for BHF and Brighthouse Holdings and the financial strength ratings for certain insurance subsidiaries on Rating Watch Negative.
Analysis · BHF · Finance
The headline numbers were already out via the same-day 8-K, but the full 10-Q carries the balance-sheet story: stockholders' equity dropped to $5,011 million from $6,768 million at year-end as accumulated other comprehensive income fell to -$5,968 million, driven by unrealized fixed-maturity losses widening to $8,931 million. It also discloses that Fitch placed BHF and certain insurance subsidiaries on Rating Watch Negative on November 5, 2026 — a live credit concern while the $70.00-per-share Aquarian merger awaits Delaware, New York and Massachusetts insurance approvals and the parties discuss extending the December 6, 2026 Outside Date. Quality of the quarter is thin: $278 million of the GAAP result came from the annual actuarial review, and $314 million ($5.42 per share) of the $527 million adjusted earnings was favorable notable items, leaving $3.68 per share ex-notables.
How filings like this one have moved
In the 30 days to Nov 5, 2026, 33.3% of the 2362 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was +0.02%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BHF was trading at $45.00 on NASDAQ in the Finance sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $41.01 to $66.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.